Search: WFRF:(Nowak Jan) >
The cascade of care...
-
Kamal, HabibaDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years
- Article/chapterEnglish2024
Publisher, publication year, extent ...
-
Wiley-Blackwell Publishing Inc.2024
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-109511
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-109511URI
-
https://doi.org/10.1111/liv.15770DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:154140314URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
BACKGROUND AND AIMS: Previous studies have shown suboptimal screening for hepatitis D virus (HDV) among patients with chronic hepatitis B (CHB). This study presents the cascade of care for HDV infection in a major secondary referral centre in Southern Stockholm, Sweden.METHODS: HBsAg+ve patients attending Karolinska University Hospital (KUH) from 1992 to 2022 were identified. The prevalence of anti-HDV and/or HDV RNA positivity, interferon (IFN) therapy and maintained virological responses (MVR) after HDV treatment were assessed. Also, time to anti-HDV testing was analysed in relation to liver-related outcomes with logistic regression.RESULTS: Among 4095 HBsAg+ve persons, 3703 (90.4%) underwent an anti-HDV screening; within a median of 1.8 months (range 0.0-57.1) after CHB diagnosis. This screening rate increased over time, to 97.9% in the last decade. Overall, 310 (8.4%) were anti-HDV+ve, of which 202 (65.2%) were HDV RNA+ve. Eighty-five (42%) received IFN, and 9 (10.6%) achieved MVR at the last follow-up. The predictive factors for anti-HDV screening were Asian origin, diagnosis after the year 2012, HIV co-infection (negative factor) and HBV DNA level < 2000 IU/mL in univariable analysis, while HIV co-infection was the only remaining factor in multivariable analysis. Delayed anti-HDV test >5 years was independently associated with worsened liver-related outcomes (adjusted odds ratio = 7.6, 95% CI 1.8-31.6).CONCLUSION: Higher frequency of HDV screening than previously published data could be seen among CHB patients at KUH in a low-endemic setting. Receiving a delayed screening test seems to be associated with worse outcomes, stressing the need of a strategy for timely HDV diagnosis.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Lindahl, KarinDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
-
Ingre, MichaelDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden; Centre for Bioinformatics and Biostatistics, Karolinska Institute, Stockholm, Sweden
(author)
-
Gahrton, CarolineDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
-
Karkkonen, KerstinDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
-
Nowak, PiotrDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
-
Vesterbacka, JanDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
(author)
-
Stål, PerDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden; Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden
(author)
-
Wedemeyer, HeinerDepartment of Gastroenterology and Hepatology, University of Hannover, Hannover, Germany
(author)
-
Duberg, Ann-Sofi,Docent,1957-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden(Swepub:oru)adg
(author)
-
Aleman, SooKarolinska Institutet
(author)
-
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, SwedenDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden; Centre for Bioinformatics and Biostatistics, Karolinska Institute, Stockholm, Sweden
(creator_code:org_t)
Related titles
-
In:Liver international: Wiley-Blackwell Publishing Inc.44:1, s. 228-2401478-32231478-3231
Internet link
Find in a library
To the university's database
- By the author/editor
-
Kamal, Habiba
-
Lindahl, Karin
-
Ingre, Michael
-
Gahrton, Carolin ...
-
Karkkonen, Kerst ...
-
Nowak, Piotr
-
show more...
-
Vesterbacka, Jan
-
Stål, Per
-
Wedemeyer, Heine ...
-
Duberg, Ann-Sofi ...
-
Aleman, Soo
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Liver internatio ...
- By the university
-
Örebro University
-
Karolinska Institutet